Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Nov 19, 2020
Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma
November 18, 2020 (Brussels, Belgium) The Plasma Protein Therapeutics Association (PPTA) welcomes the European Commission’s publication of the Inception Impact Assessment (IIA) as a necessary step in the ongoing evaluation of the EU legislation on blood, tissues, and cells (BTC).
All
Press releases
Nov 19, 2020
Inception Impact Assessment Underlines the Need for Timely Action to Decrease the Reliance on Third Countries for Plasma
November 18, 2020 (Brussels, Belgium) The Plasma Protein Therapeutics Association (PPTA) welcomes the European Commission’s publication of the Inception Impact Assessment (IIA) as a necessary step in the ongoing evaluation of the EU legislation on blood, tissues, and cells (BTC).
All
Press releases
Nov 4, 2020
PPTA Statement on the Urgent Need for Plasma Donation
COVID-19 continues to present a prolonged, global public health emergency, but PPTA remains steadfastly committed to its mission to promote the availability of — and access to — safe and effective plasma protein therapies for all patients.
All
PPTA statements
Nov 4, 2020
PPTA Statement on the Urgent Need for Plasma Donation
COVID-19 continues to present a prolonged, global public health emergency, but PPTA remains steadfastly committed to its mission to promote the availability of — and access to — safe and effective plasma protein therapies for all patients.
All
PPTA statements
Nov 3, 2020
Plasma Saves Lives: Addressing the COVID-19 Pandemic
The Pathogen Safety Steering Committee (PSSC) issued a statement confirming that the coronavirus is not a threat to the safety of plasma-deriver therapies. The statement was made available for download in multiple languages including Czech, French, German, Italian, Portugues, and Spanish.
All
Presentation
https://prezi.com/view/NWUEmOxAg50YI92g7rxx/
Nov 3, 2020
Plasma Saves Lives: Addressing the COVID-19 Pandemic
The Pathogen Safety Steering Committee (PSSC) issued a statement confirming that the coronavirus is not a threat to the safety of plasma-deriver therapies. The statement was made available for download in multiple languages including Czech, French, German, Italian, Portugues, and Spanish.
All
Presentation
https://prezi.com/view/NWUEmOxAg50YI92g7rxx/
Nov 1, 2020
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 years experience of the plasma protein manufacturers
Nanofiltration entails the filtering of protein solutions through membranes with pores of nanometric sizes that have the capability to effectively retain a wide range of viruses.
All
Publication
https://pubmed.ncbi.nlm.nih.gov/32815181/
Nov 1, 2020
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 years experience of the plasma protein manufacturers
Nanofiltration entails the filtering of protein solutions through membranes with pores of nanometric sizes that have the capability to effectively retain a wide range of viruses.
All
Publication
https://pubmed.ncbi.nlm.nih.gov/32815181/
No results found